Literature DB >> 9703201

Calcium dobesilate: pharmacology and future approaches.

T Tejerina1, E Ruiz.   

Abstract

1. Calcium dobesilate (2,5-dihydroxybenzene sulfonate) is a drug commonly used in the treatment of diabetic retinopathy and chronic venous insufficiency. 2. The pharmacology of calcium dobesilate reveals its ability to decrease capillary permeability, as well as platelet aggregation and blood viscosity. 3. Furthermore, recent data show that calcium dobesilate increases endothelium-dependent relaxation owing to an increase in nitric oxide synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703201     DOI: 10.1016/s0306-3623(98)00040-8

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  19 in total

1.  [Drug Treatment of Chronic Venous Diesease].

Authors:  Miloš D Pavlović
Journal:  Wien Med Wochenschr       Date:  2016-07-05

2.  [Role of increased tissue pressure in the pathophysiology of osteoarthritis].

Authors:  C Fricker; G Stuker; P Schawalder
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

Review 3.  Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas.

Authors:  Emily C Brantley; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

Review 4.  Microvascular complications and diabetic retinopathy: recent advances and future implications.

Authors:  Megha Barot; Mitan R Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Future Med Chem       Date:  2013-03       Impact factor: 3.808

Review 5.  Hemorrhoids: from basic pathophysiology to clinical management.

Authors:  Varut Lohsiriwat
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

Review 6.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Modulation of the intramedullary pressure responses by calcium dobesilate in a rabbit knee model of osteoarthritis.

Authors:  James E Miles; Asger Wenck; Christian Fricker; Eiliv L Svalastoga
Journal:  Acta Orthop       Date:  2011-09-06       Impact factor: 3.717

8.  Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.

Authors:  Ermelindo C Leal; João Martins; Paula Voabil; Joana Liberal; Carlo Chiavaroli; Jacques Bauer; José Cunha-Vaz; António F Ambrósio
Journal:  Diabetes       Date:  2010-07-13       Impact factor: 9.461

9.  Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Farzad Hami Adl; Dima Andalib; Hassan Khojasteh-Jafari; Kamyar Ghabili
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

10.  Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1.

Authors:  Xiaoqian Zhang
Journal:  Exp Ther Med       Date:  2012-10-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.